Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen

Product Details
Certification: CE
Disinfection: Disinfection
Color: Transparent
Still deciding? Get samples of US$ 150/Piece
Request Sample
Diamond Member Since 2022

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

  • Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
  • Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
  • Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
  • Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
  • Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
  • Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
Find Similar Products
  • Overview
  • Detailed Photos
  • Packaging & Shipping
  • Company Profile
  • Our Advantages
Overview

Basic Info.

Model NO.
Lenisna 200mg
Application
Face Body
Material
PLA+Ha
Shelf Life
3 Years
Model No.
Lenisna 200mg
Transport Package
Cartons
Specification
200mg/vial
Trademark
Lenisna
Origin
Korea
Production Capacity
1000000

Product Description

Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid  to Stimulate Skin Product Collagen

Lenisna is a hybrid filler that combines both the benefits of an immediate filling effect, resulting from the use of HA hyaluronic acid, and long-term stimulation of collagen production, thanks to the use of polylactic acid PDLLA (Poly D, L - lactide)

LENISNA is one of the most effective tissue stimulants of collagen production known in aesthetic medicine - a protein responsible for hydration, firmness and elasticity of our skin, directly speaking for its youthful appearance. The strongest cross-linked hybrid filler available on the market, which combines the effect of immediate filling provided by hyaluronic acid and, thanks to the use of polylactic acid, stimulates the skin to produce collagen.
Lenisna is designed as a time-acting filler with a concentration of 170 mg PDLLA polylactic acid and 30 mg non-crosslinked hyaluronic acid. By adjusting the amount of solution and the size of particles from 50 to 60 micrometers with a round, porous shape and combining them with non-crosslinked hyaluronic acid, a hybrid was obtained suitable for application in the subcutaneous tissue or periosteum. It is intended for the treatment of deep wrinkles, flaccidity and significant tissue losses.
The Lenisna product, due to the high concentration of polylactic acid and hyaluronic acid, is used to increase the volume of sunken areas of the face, especially to correct skin depressions such as: skin folds, wrinkles, furrows, as well as in the case of visible signs of skin aging, drooping face and flaccidity. We can successfully use it on the inner side of the thighs, stomach, buttocks and sagging arms.
Indications for the procedure

  • skin with visible signs of aging,
  • sunken areas on the face,
  • furrows,
  • wrinkles, creases,
  • firming of flaccid facial skin,
  • firming the flabby skin of the arms (pelicans)
  • firming of the skin on the abdomen, thighs and buttocks
The positive effect is visible immediately after the procedure. The effects of the therapy last for at least 24 months after two/three treatments performed 6-8 weeks apart. The recommended number of treatments is 2. After 2 weeks, collagen production begins. The treatment is especially suitable for flaccid, atrophic skin, with a lot of fine wrinkles, with a small volume or with large volume losses. Polylactic acid slowly but systematically rejuvenates the skin, thickening it and making it more attractive and radiant. The effect is completely natural.
Application procedure:
  • Subcutaneously
  • Recommended cannula size: 22-25G or needle sizes: 25-26G.
  • It is applied to the subcutaneous tissue or periosteum
  • Feeding technique: deposit
  • Recommended number of sessions: 2-3 treatments 6-8 weeks apart.
Thanks to the patented manufacturing technology, the risk of subcutaneous lumps formed when using traditional PLLA has been eliminated. Durability of the procedure lasts about 2 years. Such a long period of action of Lenisna is undoubtedly an advantage of this product.
Composition:
  • Polylactic acid (PDLLA - Poly D, L Lactyd) 170mg - particle size 50-60 micrometers,
  • Non-crosslinked HA acid 30mg - particle size 3000 kDa.

The package contains: 1 ampoule of 5 ml
Product for use by professionals only.


 

Detailed Photos
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product CollagenKorea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product CollagenKorea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product CollagenKorea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen

 

Packaging & Shipping

 

 
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
 
Company Profile

 

 
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
 
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
 
Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen
 
Our Advantages

Korea PLA Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid to Stimulate Skin Product Collagen


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier